SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs

216 - Type 2 Diabetes and Different Manifestations of Pre-Existing Cardiovascular Disease as Predictors of Specific Cardiovascular Events (ID 457)

Only SaaG posters should upload a MP3 file in this step.
Session Name
SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs
Presentation Topic
3.1 Epidemiology of cardiovascular diseases and risk factors
Presenter
Authors

Abstract

Background and Aims

Coronary artery disease (CAD) and peripheral artery disease (PAD) confer an increased risk of cardiovascular events that is particularly high when type 2 diabetes (T2DM) is present in addition to cardiovascular disease (CVD). Here, we aimed at investigating the impact of T2DM and of the manifestation of pre-existing cardiovascular disease (PAD vs. CAD) as predictors of specific cardiovascular events.

Methods

We prospectively recorded cardiovascular events over 10 years in 1777 patients with established CVD, including 1312 patients with CAD, of whom 29.3% had T2DM and 465 patients with PAD, of whom 43.9% had T2DM.

Results

T2DM after multivariate adjustment significantly predicted cardiovascular mortality (n=102; HR 1.77 [1.33-2.36]; p<0.001), myocardial infarction (n=74; HR 1.50 [1.10-2.04]; p=0.010), ischemic stroke (n=54; HR 1.69 [1.16-2.46]; p=0.007), and revascularization of non-coronary arteries (n=134; HR 1.66 [1.29-2.13]; p<0.001) independently from the manifestation of CVD. The presence of PAD versus that of CAD after adjustment for conventional cardiovascular risk factors including T2DM predicted myocardial infarction (HR 2.33 [1.61-3.37]; p<0.001) and revascularization of non-coronary arteries (HR 7.48 [5.51-10.16]; p<0.001). Neither T2DM nor the presence of PAD vs. that of CAD was significantly associated with percutaneous coronary interventions (n=246) or coronary artery bypass graftings (n=94) in our cohort.

Conclusions

We conclude that both T2DM and the manifestation of pre-existing CVD predict cardiovascular events in patients with established CVD.

Hide

Only SaaG posters should upload a MP3 file in this step.

Hide

Next ePosters
217 - The effect of rs12617336 and rs17574 DPP-4 polymorphisms in hypoalphalipoproteinemia and subclinical atherosclerosis. Results from the GEA Mexican study. (ID 423)
213 - Low-density lipoprotein cholesterol levels with the lowest all-cause mortality: 108,243 individuals in a contemporary population-based study (ID 875)
214 - The Ceramide-Based Coronary Event Risk Test (CERT) Predicts Cardiovascular Mortality in Cardiovascular Disease Patients with Type 2 Diabetes as well as in Those Without Diabetes (ID 402)
215 - Impact of LDL formula and apo B quantification on UK PCSK9i and ESC/EAS treatment thresholds in patients being investigated for familial combined hyperlipidaemia (ID 285)